4//SEC Filing
Hershberger Michael D 4
Accession 0001567619-19-002399
CIK 0001561387other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 5:34 PM ET
Size
14.9 KB
Accession
0001567619-19-002399
Insider Transaction Report
Form 4
Hershberger Michael D
Chief Financial Officer
Transactions
- Sale
Class A Common Stock
2019-02-01$40.02/sh−3,850$154,071→ 85,329 total - Sale
Class A Common Stock
2019-02-05$40.03/sh−4,687$187,608→ 40,253 total - Sale
Class A Common Stock
2019-02-04$40.31/sh−40,389$1,628,052→ 44,940 total
Holdings
- 10,000
Stock Appreciation Rights
Exercise: $10.45Exp: 2021-05-21→ Common Stock (10,000 underlying) - 40,972
Stock Appreciation Rights
Exercise: $5.20Exp: 2023-09-16→ Common Stock (40,972 underlying) - 15,000
Stock Appreciation Rights
Exercise: $4.95Exp: 2022-07-01→ Common Stock (15,000 underlying) - 22,500
Stock Appreciation Rights
Exercise: $4.99Exp: 2022-09-16→ Common Stock (22,500 underlying)
Footnotes (5)
- [F1]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.22, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F2]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $41.58, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F3]Sales made pursuant to a 10b5-1 plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.00 to $40.08, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations, Inc. (the "Company), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]These stock-settled stock appreciation rights were granted under the long Term Incentive Plan of Health Insurance Innovations, Inc. (the "Plan") and vest 20% on the first three anniversaries of grant date and 40% on the fourth anniversary, subject to the terms of the Plan and an award agreement under the Plan.
- [F5]These stock-settled stock appreciation rights were granted under the Plan and vest 25% on the first and second anniversaries of grant date and 50% on the third anniversary, subject to the terms of the Plan and an award agreement under the Plan.
Documents
Issuer
Health Insurance Innovations, Inc.
CIK 0001561387
Entity typeother
Related Parties
1- filerCIK 0001569128
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 5:34 PM ET
- Size
- 14.9 KB